Article Details

Chemomab Announces First Patient Enrolled in Phase IIa Study of CM-101 for the Treatment of ...

Retrieved on: 2021-02-02 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

Chemomab Announces First Patient Enrolled in Phase IIa Study of CM-101 for the Treatment of .... View article details on hiswai:

Excerpt

Chemomab is a privately held company supported by leading healthcare-focused investors, including OrbiMed and Peter Thiel. For more information ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up